"Masimo CEO Challenges Apple Watch's Blood Oxygen Accuracy"

Masimo CEO Joe Kiani criticized Apple for offering an unreliable blood oxygen feature on the Apple Watch, leading to a patent dispute and a US court ruling that forced Apple to stop selling certain models. Apple has disabled the blood oxygen feature on the affected models to comply with the ban, while asserting that the feature is reliable and can save lives. Studies have shown that the Apple Watch's blood oxygen monitoring results are fairly accurate and similar to those of other devices, but the dispute between Masimo and Apple is expected to continue.